YTS109 cell
YTS109-013
Phase 1 small_molecule active
Quick answer
YTS109 cell for Systemic Lupus Erythematosus is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Systemic Lupus Erythematosus
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active